Nephros (NEPH) Research & Development (2010 - 2026)
Nephros' quarterly Research & Development came in at $346000.0 in Q1 2026, up 17.29% year-on-year from $295000.0 in Q1 2025, and down 12.41% quarter-over-quarter from $395000.0 in Q4 2025.
Nephros has reported Research & Development for 17 years, with the latest figure at $346000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 17.29% year-over-year to $346000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 40.55% YoY), and the FY2025 full-year result was $1.3 million, up 47.79% from the prior year.
- Research & Development for Q1 2026 stood at $346000.0, down from $395000.0 in the prior quarter.
- The five-year high for Research & Development was $395000.0 in Q4 2025, with the low at $188000.0 in Q3 2024.
- Average Research & Development over 5 years is $277647.1, with a median of $254000.0 recorded in 2024.
- Year-over-year, Research & Development slumped 43.94% in 2022 and jumped 79.79% in 2025.
- Tracing NEPH's Research & Development over 5 years: stood at $359000.0 in 2022, then sank by 42.06% to $208000.0 in 2023, then gained by 21.15% to $252000.0 in 2024, then soared by 56.75% to $395000.0 in 2025, then retreated by 12.41% to $346000.0 in 2026.
- The last three Research & Development figures came in at $346000.0 (Q1 2026), $395000.0 (Q4 2025), and $338000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 94.27 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 15.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 189.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 44.30 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 98.66 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 139.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 346,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 295,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 212,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 221,000.00 |
| Mar 31, 2023 | 239,000.00 |
| Dec 31, 2022 | 359,000.00 |
| Sep 30, 2022 | 252,000.00 |
| Jun 30, 2022 | 273,000.00 |
| Mar 31, 2022 | 372,000.00 |
| Dec 31, 2021 | 328,000.00 |
| Sep 30, 2021 | 395,000.00 |
| Jun 30, 2021 | 487,000.00 |
| Mar 31, 2021 | 556,000.00 |
| Dec 31, 2020 | 609,000.00 |
| Sep 30, 2020 | 751,000.00 |
| Jun 30, 2020 | 836,000.00 |
| Mar 31, 2020 | 563,000.00 |
| Dec 31, 2019 | 764,000.00 |
| Sep 30, 2019 | 777,000.00 |
| Jun 30, 2019 | 793,000.00 |
| Mar 31, 2019 | 756,000.00 |
| Dec 31, 2018 | 546,000.00 |
| Sep 30, 2018 | 352,000.00 |
| Jun 30, 2018 | 352,000.00 |
| Mar 31, 2018 | 289,000.00 |
| Dec 31, 2017 | 258,000.00 |
| Sep 30, 2017 | 237,000.00 |
| Jun 30, 2017 | 277,000.00 |
| Mar 31, 2017 | 231,000.00 |
| Dec 31, 2016 | 316,000.00 |
| Sep 30, 2016 | 241,000.00 |
| Jun 30, 2016 | 254,000.00 |
| Mar 31, 2016 | 269,000.00 |
| Dec 31, 2015 | 244,000.00 |
| Sep 30, 2015 | 226,000.00 |
| Jun 30, 2015 | 164,000.00 |
| Mar 31, 2015 | 192,000.00 |
| Dec 31, 2014 | 260,000.00 |
| Sep 30, 2014 | 178,000.00 |
| Jun 30, 2014 | 180,000.00 |
| Mar 31, 2014 | 163,000.00 |
| Dec 31, 2013 | 180,000.00 |
| Sep 30, 2013 | 204,000.00 |
| Jun 30, 2013 | 259,000.00 |
| Mar 31, 2013 | 223,000.00 |
| Dec 31, 2012 | 80,000.00 |
| Sep 30, 2012 | 208,000.00 |
| Jun 30, 2012 | 199,000.00 |
| Mar 31, 2012 | 145,000.00 |
| Dec 31, 2011 | 74,000.00 |
| Sep 30, 2011 | 137,000.00 |
| Jun 30, 2011 | 117,000.00 |
| Mar 31, 2011 | 92,000.00 |
| Dec 31, 2010 | 103,000.00 |
| Sep 30, 2010 | 116,000.00 |
| Jun 30, 2010 | 71,000.00 |